Session Information
2009 Midyear Clinical Meeting
Click here to go to the previous page
Meeting the Challenges of Venous Thromboembolism Prophylaxis
Track:
Educational Sessions (CE)
Program Code: 220-L01
Date: Wednesday, December 9, 2009
Time: 4:00 PM to 5:00 PM EST
Location:
Palazzo D, Level 5
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Rachel Hroncich, PharmD, Clinical Coordinator and Residency Program Director, Presbyterian Healthcare Services
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
J. Randle Adair, DO, PhD, Attending Hospitalist and Division Chief, Internal Medicine, Presbyterian Medical Group Rachel Hroncich, PharmD, Clinical Coordinator and Residency Program Director, Presbyterian Healthcare Services
Description
Planned in cooperation with the ASHP Research and Education Foundation
ACPE Activity #204-000-09-220-L01P
1.0 Contact Hour / Knowledge-based
Educational Content: Level 2
Moderator: Rachel Hroncich, PharmD, Clinical Coordinator and Residency Program Director, Presbyterian Healthcare Services, Albuquerque, NM
4:00 p.m. – 4:05 p.m.
Announcements
4:05 p.m. – 4:10 p.m.
VTE Prophylaxis Recommendations from the 8th ACCP Guidelines
Rachel Hroncich
4:10 p.m. – 4:15 p.m.
National Goals and Regulatory Practices Pertaining to VTE Prophylaxis
Rachel Hroncich
4:15 p.m. – 4:25 p.m.
Rationale for VTE Prophylaxis and Screening
J. Randle Adair, DO, PhD, Attending Hospitalist, Presbyterian Medical Group, Albuquerque, NM
4:25 p.m. – 4:35 p.m.
Implementing a Comprehensive VTE Prophylaxis Program
J. Randle Adair
4:35 p.m. – 4:50 p.m.
VTE Screening Research Results
Mary Dallas, MD, Medical Information Officer, Presbyterian Healthcare Services, Albuquerque, NM
4:50 p.m. – 4:55 p.m.
Summary
Mary Dallas
4:55 p.m. – 5:00 p.m.
Questions, Answers, and Discussion
Learning Objectives:
ACPE Activity #204-000-09-220-L01P
1.0 Contact Hour / Knowledge-based
Educational Content: Level 2
Moderator: Rachel Hroncich, PharmD, Clinical Coordinator and Residency Program Director, Presbyterian Healthcare Services, Albuquerque, NM
4:00 p.m. – 4:05 p.m.
Announcements
4:05 p.m. – 4:10 p.m.
VTE Prophylaxis Recommendations from the 8th ACCP Guidelines
Rachel Hroncich
4:10 p.m. – 4:15 p.m.
National Goals and Regulatory Practices Pertaining to VTE Prophylaxis
Rachel Hroncich
4:15 p.m. – 4:25 p.m.
Rationale for VTE Prophylaxis and Screening
J. Randle Adair, DO, PhD, Attending Hospitalist, Presbyterian Medical Group, Albuquerque, NM
4:25 p.m. – 4:35 p.m.
Implementing a Comprehensive VTE Prophylaxis Program
J. Randle Adair
4:35 p.m. – 4:50 p.m.
VTE Screening Research Results
Mary Dallas, MD, Medical Information Officer, Presbyterian Healthcare Services, Albuquerque, NM
4:50 p.m. – 4:55 p.m.
Summary
Mary Dallas
4:55 p.m. – 5:00 p.m.
Questions, Answers, and Discussion
Learning Objectives:
- Describe national goals and regulatory practices relating to venous thromboembolism (VTE) screening and prophylaxis.
- Explain how to implement a comprehensive VTE prophylaxis program in a hospital setting.
- Explain how to make VTE prophylaxis screening automatic, reliable, and easy.
- Identify the need for VTE screening and prophylaxis.
This session is a part of:
Handout Online
